In addition to the HTML version of my CV, a PDF version is available here.
Incerti D, Thom H, Baio G, Jansen JP. R you still using Excel? The advantages of modern software tools for health technology assessment. Value in Health (in press).
Ton TG, Bennett M, Incerti D, Peneva D, Druzin M, Stevens W, Butwick A, Lee HC. Maternal and infant adverse outcomes associated with preeclampsia with and without severe features in the United States. American Journal of Perinatology (in press).
Incerti D, Curtis JR, Shafrin J, Lakdawalla DN, Jansen JP. A flexible open-source decision model for value assessment of biologic treatment for rheumatoid arthritis. Pharmacoeconomics. 2019. https://doi.org/10.1007/s40273-018-00765-2. (Full-text).
Incerti D, Browne J, Huber C, Baker CL, Makinson G, Goren A, Wilke R, Stevens W. An empirical tool for estimating the share of unmet need due to healthcare inefficiencies, suboptimal access, and lack of effective technologies. BMC Health Services Research. https://doi.org/10.1186/s12913-019-3914-7.
Incerti D, Summers N, Ton TG, Boscoe A, Chandraker A, Stevens W. The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States. Medical Decision Making Policy & Practice. 2018. Jun;3(1):2381468318781811. http://journals.sagepub.com/doi/full/10.1177/2381468318781811.
Frasco MA, Shih T, Incerti D, Diaz Espinosa O, Vania DK, Thomas N. Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1α. Journal of Medical Economics. 2017 Oct 3;20(10):1074-82. http://dx.doi.org/10.1080/13696998.2017.1357564.
Stevens W, Shih T, Incerti D, Ton TG, Lee H, Peneva D, Macones GA, Sibai BM, Jena AB. 2017. Short-term costs of preeclampsia to the United States health care system. American Journal of Obsetrics & Gynecology. 2017 Sep 1;217(3):237-48. http://dx.doi.org/10.1016/j.ajog.2017.04.032.
Shahabi A, Peneva D, Incerti D, McLaurin K, Stevens W. Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants. PharmacoEconomics-Open. 2017:1-9. https://doi.org/10.1007/s41669-017-0042-3.
Jansen JP, Incerti D, Mutebi A, Peneva, D, MacEwan JP, Stolshek B, Kaur P, Gharaibeh M, Strand V. Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators. Journal of Medical Economics. 2017 Jul 3;20(7):703-14. http://dx.doi.org/10.1080/13696998.2017.1307205 (Supplement).
Stevens W, Incerti D, Peneva D, Shrestha A, Ramaswamy K, Smith G. An Empirical Analysis of the Role of Learning by Doing in Dynamic Cost-effectiveness.
Jansen JP, Incerti D, Curtis, JR. Towards relevant and credible cost-effectiveness analysis for value assessment in the decentralized US healthcare system.
Incerti D. Racial, Ethnic and Educational Disparities in Pharmaceutical Expenditures. (PDF).
Jansen JP, Incerti D, Linthicum M. An Open-Source Consensus-Based Approach To Value Assessment. Health Affairs Blog. 2017 Dec 1.
R You Seriously Still Using Excel? The Many Advantages of Open Source Decision Modeling in Efficient Programming Languages. ISPOR Annual European Congress, Barcelona, Spain, 2018 (with Jeroen Jansen, Howard Thom, and Gianluca Baio). (PDF)
Developing flexible, iterative, and transparent decision models: a detailed look at a rheumatoid arthritis individual patient simulation. ISPOR Student Network Educational Webinar, 2018. (PDF)
Open-Source Consensus-Based Models to Improve the Cost-Effectiveness of Rheumatology Care (selected oral abstract). ACR/ARHP Annual Meeting, San Diego, 2017.
Estimates of the costs of preeclampsia to the United States health care system. March of Dimes Prematurity Research Center at Stanford University, Palo Alto, 2016 (with Thanh G.N. Ton).
Incerti D, Jansen JP. Open-source software for developing computationally efficient cost-effectiveness models to evaluate sequential treatment strategies in oncology. ISPOR Annual European Congress, Barcelona, Spain, 2018.
Jansen JP, Incerti D, Shafrin J, Frederickson A, Lakdawalla DN, Reckamp KL. A flexible open-source cost-effectiveness model for metastatic EGFR+ non-small cell lung cancer. ISPOR Annual European Congress, Barcelona, Spain, 2018.
Incerti D, Shafrin J, Lakdawalla DN, Zhao L, Linthicum M, Jansen JP. Improvement of an open-source cost-effectiveness model based on public feedback. ISPOR Annual European Congress, Barcelona, Spain, 2018.
May SG, Shafrin J, Linthicum M, Incerti D, Jansen JP, Bright J. Toward patient-centered value assessment: Lessons from the IVI Open-Source Value Project. ISPOR Annual European Congress, Barcelona, Spain, 2018.
Incerti D, Jansen JP. An Open-Source Toolkit for Developing Flexible Evidence-Based Decision and Simulation Models for Value Assessment in Oncology with R. ISPOR 23rd Annual International Meeting, Baltimore, 2018. https://doi.org/10.1016/j.jval.2018.04.1508.
Incerti D, Jansen JP. Quantifying the Importance of Model Parameters and Structural Assumptions on the Value of Treatments for Rheumatoid Arthritis using Metamodeling. ISPOR 23rd Annual International Meeting, Baltimore, 2018. https://doi.org/10.1016/j.jval.2018.04.1333.
Incerti D, Curtis JR, Lorenzi M, Jansen JP. Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis. ISPOR Annual European Congress, Glasgow, Scotland, 2017. http://dx.doi.org/10.1016/j.jval.2017.08.2098.
Incerti D, Peneva D, Shrestha A, Ramaswamy K, Smith G, Stevens W. An Empirical Analysis of the Role of Learning by Doing in Dynamic Cost-effectiveness. ISPOR Annual European Congress, Glasgow, Scotland, 2017. http://dx.doi.org/10.1016/j.jval.2017.08.215.
Jansen JP, Jeffers A, Chang K, Incerti D. An Outcomes Regression Approach for Indirect Comparisons of Survival Outcomes when Standard Network Meta-Analysis is Not Feasible. ISPOR Annual International Meeting, Boston, 2017.
Wan J, Mongan J, Incerti D, Courtier J. A Shiny New World: Creating Your Own Radiology Decision Support Webapps Using R. Radiological Society of North America, Annual Meeting, Chicago, 2016.
Shiraito Y, Incerti, D, Lopez-Moctezuma G. A Reassessment of the Resource Curse: A Bayesian Dynamic Analysis of Panel Data. Midwest Political Science Association, Annual Meeting, Chicago, 2013.
hesim, an R package for health economic simulation modeling and decision analysis that provides a general framework for integrating statistical analyses with economic evaluation. The package currently supports N-state partitioned survival models and state-transition models, as well as individualized cost-effectiveness analysis. It is designed for high performance simulation modeling including microsimulation and probabilistic sensitivity analysis with core code written in C++ (Website).
Author of the IVI-NSCLC model, an open-source simulation model for assessing the value of sequences of treatment to treat patients with epidermal growth factor receptor (EGFR) positive non-small cell lung cancer (NSCLC). Lead programmer of the R package. (GitHub)
Author of the IVI-RA model, an open-source individual patient simulation model for assessing the value of disease-modifying anti-rheumatic drugs (DMARDs) to treat rheumatoid arthritis. Lead programmer of the R package and R Shiny web apps. (GitHub)
R Shiny web applications
An R Shiny web application that aids diagnosis of skeletal dysplasias based on clinical features. (Link).
Interactive plots of parametric survival distributions. (Link).
Most experienced: R, Stata, LaTeX, Excel
Some experience: C++, Python, MySQL, Stan, JAGS
UCSD Varsity Baseball Letterman, shortstop and centerfield, 2004 – 2006